InspireMD (NYSE:NSPR) Shares Down 1.5% – What’s Next?

Shares of InspireMD, Inc. (NYSE:NSPR) were down 1.5% during trading on Monday. The company traded as low as $0.67 and last traded at $0.6895. 23,494 shares were traded during trading, a decline of 83% from the average session volume of 141,243 shares. The stock had previously closed at $0.70.

InspireMD Stock Down 2.0%

The stock has a market capitalization of $31.61 million, a price-to-earnings ratio of -0.91 and a beta of 0.83. The company’s fifty day simple moving average is $0.79 and its 200 day simple moving average is $0.99.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. Nantahala Capital Management LLC bought a new stake in shares of InspireMD during the second quarter worth approximately $2,363,876. Parkman Healthcare Partners LLC bought a new position in shares of InspireMD during the second quarter worth approximately $1,692,000. BlackRock Inc. acquired a new stake in InspireMD during the 2nd quarter worth approximately $86,000. Finally, Renaissance Technologies LLC acquired a new stake in InspireMD during the 1st quarter worth approximately $29,000. 44.78% of the stock is owned by institutional investors.

InspireMD Company Profile

InspireMD, Inc (NYSE:NSPR) is a medical device company focused on developing and commercializing products for the treatment of vascular disease. The company’s primary focus is carotid artery disease, a condition in which plaque buildup can restrict blood flow and increase the risk of stroke.

Its principal product is the CGuard Embolic Prevention System (EPS), a carotid stent system that combines a self-expanding stent with a fine mesh layer called MicroNet. The design is intended to stabilize plaque, reduce plaque protrusion through the stent, and help limit the release of embolic material during and after carotid artery procedures.